Total trials
167
Active
56
Phase 3
2
Total enrollment
22,161
Pipeline matrix
Showing 8 of 8 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Methadone | — | — | — | — | — | 1 | |
| Suzetrigine | — | — | — | — | — | 1 | |
| SGLT-2 inhibitor | — | — | — | — | — | 1 | |
| 18F-rhPSMA-7.3 | — | — | — | — | — | 1 | |
| Glucagon | — | — | — | — | — | 3 | |
| SGLT2 inhibitor | — | — | — | — | — | 1 | |
| Darolutamide | — | — | — | — | — | 1 | |
| Relugolix | — | — | — | — | — | 1 |
Next readouts
- 2017-01-13
- 2018-02-14
- 2024-07-23
- 2026-06
- 2026-07-01
- 2027-09-05
- 2028-04
- 2030-04
Top conditions
- Obesity12
- Pancreatic Cancer8
- Type 2 Diabetes8
- Stress6
- Diabetes6
- Pancreatic Neoplasms5
- Pancreatic Neoplasm4
- Burnout4
Frequently asked questions about AdventHealth
- How many clinical trials does AdventHealth have on ClinicalTrials.gov?
- AdventHealth is listed as the lead sponsor on 167 clinical trials in ClinicalTrials.gov, 56 of which are currently active (recruiting, enrolling, or ongoing).
- How many of AdventHealth's trials are in Phase 3?
- 2 of AdventHealth's trials are in Phase 3, spread across 8 active drug programs.
- What therapeutic areas does AdventHealth focus on?
- AdventHealth's most-studied conditions on ClinicalTrials.gov are Obesity, Pancreatic Cancer, Type 2 Diabetes, Stress, Diabetes.
- When are AdventHealth's next clinical trial readouts?
- AdventHealth has 8 upcoming primary-completion readouts tracked here; the soonest is “To Determine Tolerability to Glucagon Infusion in Obese Subjects”, expected around 2017-01-13.